(NASDAQ: HSCS) Heartsciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 28.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 65.97%.
Heartsciences's earnings in 2026 is -$10,259,225.On average, 4 Wall Street analysts forecast HSCS's earnings for 2027 to be -$14,100,985, with the lowest HSCS earnings forecast at -$13,548,005, and the highest HSCS earnings forecast at -$14,515,720.
In 2028, HSCS is forecast to generate -$9,841,313 in earnings, with the lowest earnings forecast at -$9,455,379 and the highest earnings forecast at -$10,130,763.